期刊
POSTGRADUATE MEDICINE
卷 122, 期 5, 页码 97-109出版社
TAYLOR & FRANCIS LTD
DOI: 10.3810/pgm.2010.09.2206
关键词
attention-deficit/hyperactivity disorder; attention-deficit disorder; comorbidity; treatment
资金
- NIDA NIH HHS [K24 DA016264] Funding Source: Medline
- NATIONAL INSTITUTE ON DRUG ABUSE [K24DA016264] Funding Source: NIH RePORTER
Attention deficit/hyperactivity disorder (ADHD) is among the most common neurobehavioral disorders requiring treatment in children and adolescents. The disorder is often chronic, with prominent symptoms and impairment spanning into adulthood. It is often associated with co-occurring disorders, including disruptive, mood, anxiety, and substance abuse disorders. The diagnosis of ADHD is clinically established by review of symptoms and impairment. The biological underpinning of the disorder is supported by genetic, neuroimaging, neurochemistry, and neuropsychological data. All aspects of an individual's life need to be considered in the diagnosis and treatment of ADHD. Multimodal treatment includes educational, family, and individual support. Psychotherapy alone and in combination with medication is helpful for treating patients with ADHD and comorbid disorders. Pharmacotherapy, including stimulants, noradrenergic agents, alpha-agonists, and antidepressants, plays a fundamental role in the long-term management of ADHD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据